Pulmonary Hypertension Society of Australia and New Zealand 2016 Scientific Abstracts

Papers included

  • Making Australia the benchmark in echocardiography databases: The National Echo Database Australia (NEDA)
  • Establishing a pulmonary hypertension exercise program at Fiona Stanley Hospital
  • Relationship between pulmonary artery wedge pressure, age, co-morbidities, and treatment response in idiopathic pulmonary arterial hypertension
  • Pulmonary arterial hypertension: effects of ERA switch to macitentan
  • Targeting the prostacyclin pathway in the treatment of connective tissue disease associated pulmonary arterial hypertension (PAH): insights from the randomized controlled GRIPHON trial with selexipag
  • Survival and health-related quality of life in incident systemic sclerosis related pulmonary arterial hypertension: a multicenter Australian cohort study
  • Critical pulmonary arterial hypertension necessitating bilateral lung transplantation
  • Percentage predicted is not superior to absolute six-minute walk distance as a predictor of mortality in pulmonary hypertension
  • Climbing Kilimanjaro: time-course changes in pulmonary pressures and gas-exchange during altitude exposure in 27 non-acclimatized climbers
  • The National Echo Database Australia (NEDA) and pulmonary hypertension
  • Scleroderma as a scapegoat: recognizing the prevalence of left-sided heart disease in patients with pulmonary hypertension and scleroderma in a tertiary referral center
  • Nutritional status, dietary intake, and quality of life in older patients with pulmonary arterial hypertension

Published in:

Pulmonary Circulation Vol 7: No 1 cover image

March 2017

Pulmonary Circulation Vol 7: No 1

View this journal

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI